These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 10820881)

  • 41. Localized experimental bone metastasis drives osteolysis and sensory hypersensitivity at distant non-tumor-bearing sites.
    Abdelaziz DM; Stone LS; Komarova SV
    Breast Cancer Res Treat; 2015 Aug; 153(1):9-20. PubMed ID: 26208488
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Treatment with ibandronate preserves bone in experimental tumour-induced bone loss.
    Kurth AH; Kim SZ; Sedlmeyer I; Hovy L; Bauss F
    J Bone Joint Surg Br; 2000 Jan; 82(1):126-30. PubMed ID: 10697328
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Protective effects of a prophylactic treatment with the bisphosphonate 3-amino-1-hydroxypropane-1,1-bisphosphonic acid on the development of tumor osteopathies in the rat: experimental studies with the Walker carcinosarcoma 256.
    Krempien B; Wingen F; Eichmann T; Müller M; Schmähl D
    Oncology; 1988; 45(1):41-6. PubMed ID: 3340393
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of combined prostaglandin and alendronate treatment on the histomorphometry and biomechanical properties of bone in ovariectomized rats.
    Lauritzen DB; Balena R; Shea M; Seedor JG; Markatos A; Le HM; Toolan BC; Myers ER; Rodan GA; Hayes WC
    J Bone Miner Res; 1993 Jul; 8(7):871-9. PubMed ID: 8352069
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Both hPTH(1-34) and bFGF increase trabecular bone mass in osteopenic rats but they have different effects on trabecular bone architecture.
    Lane NE; Yao W; Kinney JH; Modin G; Balooch M; Wronski TJ
    J Bone Miner Res; 2003 Dec; 18(12):2105-15. PubMed ID: 14672345
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mechanoregulation may drive osteolysis during bone metastasis: A finite element analysis of the mechanical environment within bone tissue during bone metastasis and osteolytic resorption.
    Verbruggen ASK; McNamara LM
    J Mech Behav Biomed Mater; 2023 Feb; 138():105662. PubMed ID: 36630755
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A novel flavonoid C-glucoside from Ulmus wallichiana preserves bone mineral density, microarchitecture and biomechanical properties in the presence of glucocorticoid by promoting osteoblast survival: a comparative study with human parathyroid hormone.
    Khan MP; Mishra JS; Sharan K; Yadav M; Singh AK; Srivastava A; Kumar S; Bhaduaria S; Maurya R; Sanyal S; Chattopadhyay N
    Phytomedicine; 2013 Nov; 20(14):1256-66. PubMed ID: 23928508
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Minodronic acid (ONO-5920/YM529) prevents decrease in bone mineral density and bone strength, and improves bone microarchitecture in ovariectomized cynomolgus monkeys.
    Mori H; Tanaka M; Kayasuga R; Masuda T; Ochi Y; Yamada H; Kishikawa K; Ito M; Nakamura T
    Bone; 2008 Nov; 43(5):840-8. PubMed ID: 18718565
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Bisphosphonate treatment affects trabecular bone apparent modulus through micro-architecture rather than matrix properties.
    Day JS; Ding M; Bednarz P; van der Linden JC; Mashiba T; Hirano T; Johnston CC; Burr DB; Hvid I; Sumner DR; Weinans H
    J Orthop Res; 2004 May; 22(3):465-71. PubMed ID: 15099622
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Inhibition of osteolytic bone metastasis of breast cancer by combined treatment with the bisphosphonate ibandronate and tissue inhibitor of the matrix metalloproteinase-2.
    Yoneda T; Sasaki A; Dunstan C; Williams PJ; Bauss F; De Clerck YA; Mundy GR
    J Clin Invest; 1997 May; 99(10):2509-17. PubMed ID: 9153295
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The bone biologic effects of zoledronate in healthy dogs and dogs with malignant osteolysis.
    Fan TM; de Lorimier LP; Garrett LD; Lacoste HI
    J Vet Intern Med; 2008; 22(2):380-7. PubMed ID: 18346146
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Local treatment of mixed osteolytic/osteoblastic spinal metastases: is photodynamic therapy effective?
    Wise-Milestone L; Akens MK; Lo VC; Yee AJ; Wilson BC; Whyne CM
    Breast Cancer Res Treat; 2012 Jun; 133(3):899-908. PubMed ID: 22058005
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Protective effects of sodium daidzein sulfonate on trabecular bone in ovariectomized rats.
    Ren P; Ji H; Shao Q; Chen X; Han J; Sun Y
    Pharmacology; 2007; 79(3):129-36. PubMed ID: 17179740
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prophylactic treatment of skeletal metastases, tumor-induced osteolysis, and hypercalcemia in rats with the bisphosphonate Cl2MBP.
    Krempien B; Manegold C
    Cancer; 1993 Jul; 72(1):91-8. PubMed ID: 8508433
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Long-term protective effects of zoledronic acid on cancellous and cortical bone in the ovariectomized rat.
    Gasser JA; Ingold P; Venturiere A; Shen V; Green JR
    J Bone Miner Res; 2008 Apr; 23(4):544-51. PubMed ID: 18072878
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Current controversies in bisphosphonate therapy.
    Paul GR
    Orthopedics; 2010 Jul; 33(7):468. PubMed ID: 20608598
    [No Abstract]   [Full Text] [Related]  

  • 57. Inhibition by diphosphonates of bone resorption induced by the Walker tumor of the rat.
    Jung A; Bornand J; Mermillod B; Edouard C; Meunier PJ
    Cancer Res; 1984 Jul; 44(7):3007-11. PubMed ID: 6233002
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Angiogenesis inhibitor TNP-470 inhibits human breast cancer osteolytic bone metastasis in nude mice through the reduction of bone resorption.
    Sasaki A; Alcalde RE; Nishiyama A; Lim DD; Mese H; Akedo H; Matsumura T
    Cancer Res; 1998 Feb; 58(3):462-7. PubMed ID: 9458090
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The influence of osteolytic substances on the production of osseous metastases from Walker 256 sarcoma in rats.
    Graham WP; Tragus ET; Blakemore WS
    J Surg Oncol; 1974; 6(2):117-21. PubMed ID: 4822896
    [No Abstract]   [Full Text] [Related]  

  • 60. Osteolysis and pain due to experimental bone metastases are improved by treatment with rapamycin.
    Abdelaziz DM; Stone LS; Komarova SV
    Breast Cancer Res Treat; 2014 Jan; 143(2):227-37. PubMed ID: 24327332
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.